Search
for
Sort by
Research 481–510 of 1000+
- Ritlecitinib for the Management of Alopecia Areata: A Narrative Review of Real-World Evidence and Selected Post Hoc Analyses
- Dermoscopy of Chronic Radiation-Induced Dermatitis in Patients with Head and Neck Cancers Treated with Radiotherapy
- АСПЕКТИ ПАТОГЕНЕЗУ ТА ДИФЕРЕНЦІЙОВАНІ ПІДХОДИ ДО ЛІКУВАННЯ ПАТОЛОГІЇ ШКІРИ У ЖІНОК РАННЬОГО РЕПРОДУКТИВНОГО ВІКУ З ПОРУШЕННЯМИ МЕНСТРУАЛЬНОГО ЦИКЛУ
- Quality of life and patient-reported side effects of low-dose oral minoxidil in treating female pattern hair loss
- РОЛЬ ОКСИДАТИВНОГО СТРЕССА И МИТОХОНДРИАЛЬНОЙ ДИСФУНКЦИИ В ПРОГРЕССИРОВАНИИ АЛОПЕЦИИ
- THE IMPACT OF HOMOCYSTEINE IN LUPUS ERYTHEMATOSUS: A LINK OF INFLAMMATION, SKIN AND CARDIOVASCULAR RISK
- Disfunción eréctil : función endotelial e interacción hormonal, efectos sobre la salud vascular -De la fisiopatología molecular a los aspectos clínicos-
- Three Cases of Canine Dermatomyositis-Like Disease
- Pain in pancreatic cancer: A medical oncologist's view
- Antiandrogens as Therapies for COVID-19: A Systematic Review
- A review of Janus kinase inhibitor use in scarring alopecia
- MR Imaging of Hair and Scalp for the Evaluation of Androgenetic Alopecia
- Dermatologic therapy: December 1987 to December 1988
- Trichoscopic features of frontal fibrosing alopecia: Results in 249 patients
- Use of trilostane for the treatment of pituitary‐dependent hyperadrenocorticism in a cat
- An Emollient PLUS Balm Is Useful for the Management of Xerosis in Patients Treated for Cancer: A Real-World, Prospective, Observational, Multicenter Study
- Experts’ view on the management of scalp seborrheic dermatitis in Italy
- Alopecia areata: a review of diagnosis, pathogenesis and the therapeutic landscape
- Pathological sequelae of long-haul COVID
- Is COVID-19 Gender-sensitive?
- Late-Onset Systemic Lupus Erythematosus
- Trichoscopy update 2011
- What’s Sex Got to Do With COVID-19? Gender-Based Differences in the Host Immune Response to Coronaviruses
- THE PATHOGENESIS OF ALOPECIA AREATA
- Racial variations in COVID‐19 deaths may be due to androgen receptor genetic variants associated with prostate cancer and androgenetic alopecia. Are anti‐androgens a potential treatment for COVID‐19?
- Insulin Resistance and Skin Diseases
- Distinguishing Androgenetic Alopecia From Chronic Telogen Effluvium When Associated in the Same Patient
- SARS-CoV-2 Non-Structural Proteins and Their Roles in Host Immune Evasion
- Are sex discordant outcomes in COVID-19 related to sex hormones?
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies